Search
Organon & Co
OGNAdd to Watchlist
13.350USD
+0.030+0.23%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
3.51BMarket Cap
14.14P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.23%
5 Days
+0.45%
1 Month
+93.20%
6 Months
+96.90%
Year to Date
+86.19%
1 Year
+53.27%
TradingKey Stock Score of Organon & Co
Currency: USD Updated: 2026-05-08Key Insights
Organon & Co's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 66 out of 156 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 10.40.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Organon & Co's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Organon & Co Highlights
StrengthsRisks
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 34.38%.
Overvalued
The company’s latest PE is 14.14, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 202.76M shares, decreasing 16.34% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 5.39K shares of this stock.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
10.400
Target Price
-21.92%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Organon & Co News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Organon & Co Info
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
Ticker SymbolOGN
CompanyOrganon & Co
CEOMorrissey (Joseph T)
Websitehttps://www.organon.com/
Related Instruments
-2.75%
-0.53%
-0.67%
+0.54%
+0.20%
-0.82%
+0.79%
-2.04%
+0.61%
-1.48%
-0.14%
+1.13%
+0.30%
-0.20%
-2.42%
+0.82%
0.00%
-1.05%
-0.65%
-0.86%Popular Instruments
92.193
-2.977 (-3.13%)
293.320
+5.817 (+2.02%)
215.200
+3.717 (+1.76%)
4714.280
+29.030 (+0.62%)
480.000
+16.095 (+3.47%)
1562.340
+222.380 (+16.60%)
746.810
+100.160 (+15.49%)
400.800
+2.723 (+0.68%)
81170.010
+394.510 (+0.49%)
428.350
+16.560 (+4.02%)
